| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 650163 | 66300 | ATACAND 32 mg COMPRIMIDOS | ATACAND 32 mg COMPRIMIDOS, 28 comprimidos | 32 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/66300/66300_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/66300/66300_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 25535 | 2495 | 2004-09-20 | 1 | 1 | 1 | 2004-09-20 | 2004-09-20 | 1 | 2011-10-24 | View Edit Delete | ||||||||||||
| 654119 | 67669 | GLIMEPIRIDA KERN PHARMA 2 mg COMPRIMIDOS EFG | GLIMEPIRIDA KERN PHARMA 2 mg COMPRIMIDOS EFG, 120 comprimidos | 2 mg | 5 | 120 | 10 | 120 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/67669/67669_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/67669/67669_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1534 | 1534 | 2006-03-29 | 1 | 1 | 1 | 2006-03-29 | 2006-03-29 | 1 | 2011-10-17 | View Edit Delete | ||||||||||||
| 654121 | 67670 | GLIMEPIRIDA KERN PHARMA 4 mg COMPRIMIDOS EFG | GLIMEPIRIDA KERN PHARMA 4 mg COMPRIMIDOS EFG, 120 comprimidos | 4 mg | 5 | 120 | 10 | 120 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/67670/67670_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/67670/67670_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1534 | 1534 | 2006-03-29 | 1 | 1 | 1 | 2006-03-29 | 2006-03-29 | 1 | 2011-10-17 | View Edit Delete | ||||||||||||
| 719808 | 82627 | ATORVASTATINA ALMUS PHARMA 10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ATORVASTATINA ALMUS PHARMA 10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos | 10 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/82627/82627_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/82627/82627_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 37937 | 37937 | 2018-02-02 | 1 | 1 | 1 | 2018-02-02 | 2018-02-02 | 1 | 2020-01-27 | View Edit Delete | ||||||||||||
| 719811 | 82628 | ATORVASTATINA ALMUS PHARMA 20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ATORVASTATINA ALMUS PHARMA 20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos | 20 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/82628/82628_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/82628/82628_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 37937 | 37937 | 2018-02-02 | 1 | 1 | 1 | 2018-02-02 | 2018-02-02 | 1 | 2020-01-27 | View Edit Delete | ||||||||||||
| 719814 | 82629 | ATORVASTATINA ALMUS PHARMA 40 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ATORVASTATINA ALMUS PHARMA 40 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos | 40 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/82629/82629_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/82629/82629_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 37937 | 37937 | 2018-02-02 | 1 | 1 | 1 | 2018-02-02 | 2018-02-02 | 1 | 2020-01-27 | View Edit Delete | ||||||||||||
| 719818 | 82630 | ATORVASTATINA ALMUS PHARMA 80 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ATORVASTATINA ALMUS PHARMA 80 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos | 80 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/82630/82630_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/82630/82630_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 37937 | 37937 | 2018-02-02 | 1 | 1 | 1 | 2018-02-02 | 2018-02-02 | 1 | 2020-01-27 | View Edit Delete | ||||||||||||
| 722073 | 3400939239989 | OPIREN FLAS 30 MG COMPRIMIDOS BUCODISPERSABLES | OPIREN FLAS 30 MG COMPRIMIDOS BUCODISPERSABLES, 28 comprimidos | 30 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | No Disponible | No Disponible | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34756 | 43579 | 2018-06-13 | 1 | 1 | 1 | 2018-06-14 | 2018-06-13 | 1 | 2022-12-29 | View Edit Delete | ||||||||||||
| 724306 | 81997 | ATORVASTATINA STADAGEN 80 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ATORVASTATINA STADAGEN 80 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG 28 comprimidos (PVC-PE-PVDC-AL) | 80 mg | 5 | 28 | 10 | 28 comprimidos (PVC-PE-PVDC-AL) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/81997/81997_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/81997/81997_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6220 | 6220 | 2018-02-22 | 1 | 1 | 1 | 2018-02-22 | 2018-12-18 | 1 | 2020-10-22 | View Edit Delete | ||||||||||||
| 724307 | 81996 | ATORVASTATINA STADAGEN 10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ATORVASTATINA STADAGEN 10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG 28 comprimidos (PVC-PE-PVDC-AL) | 10 mg | 5 | 28 | 10 | 28 comprimidos (PVC-PE-PVDC-AL) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/81996/81996_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/81996/81996_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6220 | 6220 | 2018-02-21 | 1 | 1 | 1 | 2018-02-21 | 2018-12-18 | 1 | 2020-10-22 | View Edit Delete | ||||||||||||
| 724308 | 81999 | ATORVASTATINA STADAGEN 20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ATORVASTATINA STADAGEN 20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG 28 comprimidos (PVC-PE-PVDC-AL) | 20 mg | 5 | 28 | 10 | 28 comprimidos (PVC-PE-PVDC-AL) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/81999/81999_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/81999/81999_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6220 | 6220 | 2018-02-21 | 1 | 1 | 1 | 2018-02-21 | 2018-12-18 | 1 | 2020-10-22 | View Edit Delete | ||||||||||||
| 724309 | 81998 | ATORVASTATINA STADAGEN 40 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ATORVASTATINA STADAGEN 40 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG 28 comprimidos (PVC-PE-PVDC-AL) | 40 mg | 5 | 28 | 10 | 28 comprimidos (PVC-PE-PVDC-AL) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/81998/81998_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/81998/81998_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6220 | 6220 | 2018-02-21 | 1 | 1 | 1 | 2018-02-21 | 2018-12-18 | 1 | 2020-10-22 | View Edit Delete | ||||||||||||
| 732550 | 340039239989IP | OPIREN FLAS 30 mg COMPRIMIDOS BUCODISPERSABLES | OPIREN FLAS 30 mg COMPRIMIDOS BUCODISPERSABLES, 28 comprimidos | 30 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | No Disponible | No Disponible | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34756 | 23628 | 2021-12-23 | 1 | 1 | 1 | 2021-12-24 | 2021-12-23 | 1 | 2022-02-22 | View Edit Delete | ||||||||||||
| 732606 | 8926-04-02-2013 | ATACAND 32 mg COMPRIMIDOS | ATACAND 32 mg COMPRIMIDOS, 28 comprimidos | 32 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/8926-04-02-2013/8926-04-02-2013_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 25535 | 43579 | 2022-01-14 | 1 | 1 | 1 | 2022-01-15 | 2022-01-14 | 1 | 2022-04-06 | View Edit Delete | ||||||||||||
| 756685 | 87877 | FESOTERODINA ALTER 4 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG | FESOTERODINA ALTER 4 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG, 28 comprimidos | 4 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/87877/87877_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/87877/87877_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 137 | 137 | 2022-06-20 | 1 | 1 | 1 | 2022-06-21 | 2022-06-20 | 1 | 2022-10-10 | View Edit Delete | ||||||||||||
| 756686 | 87878 | FESOTERODINA ALTER 8 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG | FESOTERODINA ALTER 8 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG, 28 comprimidos | 8 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/87878/87878_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/87878/87878_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 137 | 137 | 2022-06-20 | 1 | 1 | 1 | 2022-06-21 | 2022-06-20 | 1 | 2022-10-10 | View Edit Delete | ||||||||||||
| 762804 | 3400939239989IP1 | OPIREN FLAS 30 MG COMPRIMIDOS BUCODISPERSABLES | OPIREN FLAS 30 MG COMPRIMIDOS BUCODISPERSABLES, 28 comprimidos | 30 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/3400939239989IP1/3400939239989IP1_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34756 | 26669 | 2023-05-26 | 1 | 1 | 1 | 2023-05-27 | 2023-05-26 | 1 | 2023-06-21 | View Edit Delete | ||||||||||||
| 870519 | 65474 | OPIREN FLAS 15 mg COMPRIMIDOS BUCODISPERSABLES | OPIREN FLAS 15 mg COMPRIMIDOS BUCODISPERSABLES , 28 comprimidos | 15 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/65474/65474_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/65474/65474_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 70973 | 70973 | 2003-07-21 | 1 | 1 | 1 | 2003-07-22 | 2003-07-21 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 872622 | 65475 | OPIREN FLAS 30 mg COMPRIMIDOS BUCODISPERSABLES | OPIREN FLAS 30 mg COMPRIMIDOS BUCODISPERSABLES , 28 comprimidos | 30 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/65475/65475_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/65475/65475_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 70973 | 70973 | 2003-07-21 | 1 | 1 | 1 | 2003-07-22 | 2003-07-21 | 1 | 2012-01-02 | View Edit Delete |